Literature DB >> 28929191

Overview of LAG-3-Expressing, IL-10-Producing Regulatory T Cells.

Keishi Fujio1, Kazuhiko Yamamoto2, Tomohisa Okamura2.   

Abstract

Regulatory T cells (Treg cells) play crucial roles in the induction of peripheral tolerance to self- and foreign-antigens. IL-10-producing regulatory T cells (IL-10-producing Treg cells) constitute a Treg cell subset characterized by the production of high amounts of IL-10, cytokine-mediated immunosuppressive capabilities, and independence of Foxp3 expression for their suppressive activity. In the past decade, identifying naturally occurring IL-10-producing Treg cells was difficult due to the lack of suitable surface markers. More recently, lymphocyte activation gene 3 (LAG-3) is a CD4 homologue that has been identified as a marker for IL-10-producing Treg cells. CD4+CD25-LAG3+ T cells produce large amounts of IL-10 and suppress colitis in a mouse model. These CD4+CD25-LAG3+ Treg cells also exhibit suppressive activity in murine models of lupus and humoral immunity in a TGF-β3-dependent manner. Moreover, the combined expression of LAG-3 and CD49b identifies IL-10-producing Treg cells in mice and humans more specifically. Recently, LAG-3 has gained more attention in the context of immune checkpoints because it believed to be related to T cell tolerance and exhausted T cells that infiltrate the tumor microenvironment. Tumors and the tumor microenvironment promote development of IL-10-producing Treg cells and foster tumor growth. This response might interfere with protective immune responses. Understanding LAG-3-expressing IL-10-producing Treg cells may contribute to the development of novel therapeutic strategies in immune-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28929191     DOI: 10.1007/82_2017_59

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  12 in total

1.  Intranasal administration of abatacept enhances IL-35+ and IL-10+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.

Authors:  Maha Fahad Alenazy; Fatemeh Saheb Sharif-Askari; Mohammed S El-Wetidy; Narjes Saheb Sharif-Askari; Ibrahim Yaseen Hachim; Mohammad-Hani Temsah; Basema Saddik; Roua Al-Kufaidy; Maha A Omair; Yasser A Alshawakir; Amany Adulgadel Fathaddin; Suad Hannawi; Qutayba Hamid; Mohammed A Omair; Saleh Al-Muhsen; Rabih Halwani
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

2.  STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.

Authors:  Mingming Yin; Jinlong Hu; Zhongxu Yuan; Guangyi Luo; Jiaming Yao; Rundong Wang; Dongquan Liu; Baoqiang Cao; Wenyong Wu; Zhiqi Hu
Journal:  Cell Cycle       Date:  2022-02-07       Impact factor: 5.173

3.  Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.

Authors:  Negin Shokrgozar; Mehran Karimi; Hossein Golmoghaddam; Narges Rezaei; Vida Moayed; Sedigheh Sharifzadeh; Nargess Arandi
Journal:  Ann Hematol       Date:  2021-07-29       Impact factor: 3.673

4.  The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.

Authors:  Yael Renert-Yuval; Ester Del Duca; Ana B Pavel; Milie Fang; Rachel Lefferdink; Jianni Wu; Aisleen Diaz; Yeriel D Estrada; Talia Canter; Ning Zhang; Annette Wagner; Sarah Chamlin; James G Krueger; Emma Guttman-Yassky; Amy S Paller
Journal:  J Allergy Clin Immunol       Date:  2021-01-13       Impact factor: 14.290

5.  Ectopic expression of LAG-3 in non-small-cell lung cancer cells and its clinical significance.

Authors:  Chenglong Ma; Xiao Sun; Dong Shen; Yuejun Sun; Naifu Guan; Chunjian Qi
Journal:  J Clin Lab Anal       Date:  2020-02-20       Impact factor: 2.352

6.  Response of regulatory T cells to classic heat stroke in mice.

Authors:  Jie Hu; Hong-Jun Kang; Chao Liu; Pan Hu; Meng-Meng Yang; Fei-Hu Zhou
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

Review 7.  Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Authors:  Georgios K Vasileiadis; Efthymios Dardiotis; Athanasios Mavropoulos; Zisis Tsouris; Vana Tsimourtou; Dimitrios P Bogdanos; Lazaros I Sakkas; Georgios M Hadjigeorgiou
Journal:  Auto Immun Highlights       Date:  2018-11-10

Review 8.  Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses?

Authors:  Michael Kuske; Maximilian Haist; Thomas Jung; Stephan Grabbe; Matthias Bros
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

Review 9.  Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

10.  Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.

Authors:  Yue Gao; Lingxi Chen; Guangyao Cai; Xiaoming Xiong; Yuan Wu; Ding Ma; Shuai Cheng Li; Qinglei Gao
Journal:  Oncoimmunology       Date:  2020-04-30       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.